Skip to the page
pepts.wiki

We are not doctors and nothing here is medical advice. Always consult a medical professional first. Why we say this

Animal and cell studiesStub

IGF-1 DES

Truncated IGF-1 analogue

A form of insulin-like growth factor 1 lacking its first three amino acids, with low affinity for IGF binding proteins.

Reconstitution calculator

At a glance

Animal and cell studies

The published evidence is from animals and cells. Little or nothing is published from controlled trials in people.

This page is a stub

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

How strong is the evidence

How far it has climbed

Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.

  1. Licensed medicine

    A regulator has reviewed the trials and licensed it for a named use.

  2. Phase 3

    Large randomized trials, often thousands of people, against placebo or a standard treatment.

  3. Phase 2

    Mid-sized trials that measure dose against effect in people with the condition.

  4. Phase 1 and early human studies

    First studies in people: safety, and how the body handles it.

  5. Cells and animals: IGF-1 DES

    Laboratory and animal work. An animal result is not a result in people.

198
papers on PubMed
92
of them in people
0
randomized trials
7
reviews

A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16

Handling and reconstitution

From powder to a measured sample

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. Read the vial

    The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.

  2. 2. Add the diluent

    A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.

  3. 3. Work out the strength

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. Measure the sample

    Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.

The calculator below does the arithmetic and shows its working.

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on IGF-1 DES itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of IGF-1 DES; no amount here is a recommendation.

IGF-1 DES: on PubMed

What PubMed held for IGF-1 DES on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

198
papers
92
in humans
0
clinical trials
0
randomized trials
2012: 0 papers122013: 1 papers2014: 0 papers142015: 0 papers2016: 0 papers162017: 0 papers2018: 0 papers182019: 0 papers2020: 0 papers202021: 2 papers2022: 2 papers222023: 0 papers2024: 1 papers242025: 0 papers2026: 0 papers so far26
Papers per year, 2012 to 2026. The most in one year: 2.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Des(1-3)IGF-I: a truncated form of insulin-like growth factor-I

    ReviewBallard FJ, Wallace JC, Francis GL, et al. The international journal of biochemistry & cell biology, 1996. PMID 8930132

  2. Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue

    StudyCrescioli C, Villari D, Forti G, et al. Molecular and cellular endocrinology, 2002. PMID 12573816

  3. Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples

    StudyThomas A, Walpurgis K, Thevis M Journal of mass spectrometry : JMS, 2024. PMID 38197510

  4. Probing for peptidic drugs (2-10 kDa) in doping control blood samples

    StudyThomas A, Thilmany S, Hofmann A, et al. Analytical science advances, 2022. PMID 38716080

  5. Vitamin D and benign prostatic hyperplasia -- a review

    ReviewEspinosa G, Esposito R, Kazzazi A, et al. The Canadian journal of urology, 2013. PMID 23930605

  6. IGF-I and its variant, des-(1-3)IGF-I, enhance growth in rats with reduced renal mass

    StudyMartin AA, Tomas FM, Owens PC, et al. The American journal of physiology, 1991. PMID 1928375

Search used: ("des(1-3)IGF-I"[tiab] OR "des(1-3) IGF-I"[tiab] OR "des(1-3)IGF-1"[tiab]). Run it on PubMed

Research links

Also in GH axis